Pfizer Hired 600 Employees Due To 'Large Increase Of Adverse Event Reports': Document
Pfizer Hired 600 Employees Due To 'Large Increase Of Adverse Event Reports': Document
by Zachary Stieber via The Epoch Times (emphasis ours), April 10, 2022
Pfizer hired 600
employees in the months after its COVID-19 vaccine was authorized in the United
States due to the “large increase” of reports of side effects linked to the
vaccine, according to a document prepared by the company.
Pfizer has “taken a
multiple actions to help alleviate the large increase of adverse event
reports,” according to the document. “This includes significant technology
enhancements, and process and workflow solutions, as well as increasing the
number of data entry and case processing colleagues.”
At the time when the
document—from the first quarter of 2021—was sent to the U.S. Food and Drug
Administration (FDA), Pfizer had onboarded about 600 extra full-time
workers to deal with the jump.
“More are joining each
month with an expected total of more than 1,800 additional resources by the end
of June 2021,” Pfizer said.
The document was
titled a “cumulative analysis of post-authorization adverse event reports” of
Pfizer’s vaccine received through Feb. 28, 2021. It was approved by the FDA on
April 30, 2021.
The document was not
made public until the Public Health and Medical Professionals for
Transparency sued the FDA after the agency claimed it needed
decades to produce all the documents relating to the emergency use
authorization granted to the company for the vaccine.
Under an
agreement reached in February, the
FDA must produce a certain number of pages each month.
The analysis of
adverse event reports was previously disclosed to the health transparency
group, but certain portions were redacted (pdf), including the
number of workers Pfizer onboarded to deal with the jump in adverse event
reports.
“We asked that the
redactions on page 6 of this report be lifted and the FDA agreed without
providing an explanation,” Aaron Siri, a lawyer representing the plaintiffs,
told The Epoch Times in an email.
After the document was
produced, the FDA determined that the three redactions on that page “could be
lifted,” an FDA spokesperson told The Epoch Times via email.
The redactions had
been made under (b) (4) of the Freedom of Information Act, which lets
agencies “withhold trade secrets and commercial or financial information
obtained from a person which is privileged or confidential.”
The unredacted version
of the document also now shows that approximately 126 million doses of Pfizer
were shipped around the world since the company received the first clearance,
from U.S. regulators, on Dec. 1, 2020. The shipments took place through Feb.
28, 2021.
It was unclear how
many of those doses had been administered as of that date.
Pfizer did not respond
to emailed questions, including how many workers it has onboarded to deal with
adverse events.
The companies that
manufacture the other two COVID-19 vaccines that U.S. regulators have cleared,
Moderna and Johnson & Johnson, did not respond when asked if they have seen
an increase in adverse events and if they have hired more employees to deal
with reports.
The number of
post-vaccination adverse event reports to the Vaccine Adverse Event
Reporting System, jointly run by the FDA and the Centers for Disease Control
and Prevention, has spiked since
the vaccines were first cleared.
Problems linked to the
vaccines include heart inflammation, blood clotting, and severe allergic shock.
Federal officials say the vaccines’ benefits outweigh the risks, but some experts are increasingly questioning that assertion, particularly for certain populations.
Comments
Post a Comment